Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension
NCT05001945
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension, Renal
Interventions
DRUG:
MLS-101 (Part I)
OTHER:
Placebo (Part I)
OTHER:
Placebo (Part II)
DRUG:
MLS-101 (Part II)
Sponsor
Mineralys Therapeutics Inc.